Literature DB >> 7396452

Effect of protein binding on the penetration of nonmetabolized cephalosporins into atrial appendage and pericardial fluids in open-heart surgical patients.

C H Nightingale, J J Klimek, R Quintiliani.   

Abstract

At various times before surgery, 33 patients undergoing coronary artery bypass or cardiac valve replacement surgery received a single 2.0-g dose of either cefazolin or cephradine. Simultaneous single serum, atrial appendage, and pericardial fluid samples were obtained from the patients at various times and analyzed for drug content. Compared with cephradine, cefazolin yielded higher total serum, atrial appendage, and pericardial fluid levels. Unbound (free) levels of cephradine in serum and pericardial fluid were, however, higher than those of cefazolin. It remains uncertain whether the higher and more prolonged total levels of cefazolin in the right atrial appendage and in serum, or the higher free levels of cephradine in pericardial fluid and in serum, provide either one with a therapeutic advantage.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7396452      PMCID: PMC283837          DOI: 10.1128/AAC.17.4.595

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

Review 1.  Pharmacokinetics and clinical use of cephalosporin antibiotics.

Authors:  C H Nightingale; D S Greene; R Quintiliani
Journal:  J Pharm Sci       Date:  1975-12       Impact factor: 3.534

2.  The effective period of preventive antibiotic action in experimental incisions and dermal lesions.

Authors:  J F Burke
Journal:  Surgery       Date:  1961-07       Impact factor: 3.982

3.  Binding rate of antibacterials to serum proteins.

Authors:  D S Greene; R Quintiliani; C H Nightingale
Journal:  J Pharm Sci       Date:  1977-11       Impact factor: 3.534

4.  Endocarditis associated with intracardiac prostheses. Diagnosis, management, and prophylaxis.

Authors:  R A Amoury; F O Bowman; J R Malm
Journal:  J Thorac Cardiovasc Surg       Date:  1966-01       Impact factor: 5.209

5.  Antibiotics and cardiac surgery.

Authors:  W A Reed
Journal:  J Thorac Cardiovasc Surg       Date:  1965-12       Impact factor: 5.209

6.  Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluid.

Authors:  H P Bassaris; R Quintiliani; E G Maderazo; R C Tilton; C H Nightingale
Journal:  Curr Ther Res Clin Exp       Date:  1976-01

7.  Penetration of cephapirin and cephalothin into the right atrial appendage and pericardial fluid of patients undergoing open-heart surgery.

Authors:  R Quintiliani; J Klimek; C H Nightingale
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

  7 in total
  6 in total

1.  Antibiotic tissue penetration.

Authors:  B A Cunha
Journal:  Bull N Y Acad Med       Date:  1983-06

2.  An Overview of the Protein Binding of Cephalosporins in Human Body Fluids: A Systematic Review.

Authors:  C Jongmans; A E Muller; P Van Den Broek; B De Melo Cruz De Almeida; C Van Den Berg; J Van Oldenrijk; P K Bos; B C P Koch
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

3.  Penetration of moxalactam and cefazolin into atrial appendage after simultaneous intramuscular or intravenous administration.

Authors:  R E Polk; J E Smith; K Ducey; R R Lower
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

4.  Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum, and intercostal muscle of patients undergoing open heart surgery.

Authors:  L D Mullany; M A French; C H Nightingale; H B Low; L H Ellison; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

5.  Serum and tissue concentrations of cefoxitin and cefotaxime in women undergoing hysterectomy.

Authors:  R L White; C H Nightingale; R Quintiliani; K F Whitaker; R F Jones; W H Tripp
Journal:  Drugs       Date:  1988       Impact factor: 9.546

6.  Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion.

Authors:  R E Polk; B J Kline; S M Markowitz
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.